Patients with Multidrug-Resistant Tuberculosis with Low CD4+ T Cell Counts Have Impaired Th1 Responses

Journal of Immunology

Volumn 158, Issue 1, 1997, Pages 492-500

  McDyer, John F ^a   Hackley, Mimi N ^b   Walsh, Thomas E ^c   Cook, James L ^b   Seder, Robert A ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^c Montgomery Co Tuberculosis Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4;

ARTICLE; BIOSYNTHESIS; CD4 LYMPHOCYTE COUNT; DRUG EFFECT; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; TH1 CELL; TUBERCULOSIS;

CD4 LYMPHOCYTE COUNT; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-2; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; TH1 CELLS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 0030636796     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Dolin, P. J., M. C. Raviglione, and A. Kochi. 1994. Global tuberculosis incidence and mortality during 1990-2000. Bull. W. H. O. 72:213.
2. Raviglione, M. C., D. E. Snider, Jr., and A. Kochi. 1995. Global epidemiology of tuberculosis. JAMA 273:220.
3. Modlin, R. L., and P. F. Barnes. 1995. IL-12 and the human response to Mycobacteria. Res. Immunol. Rev. 146:526.
4. Orme, I. M., and F. M. Collins, 1983. Protection against Mycobacterium tuberculosis infection by adoptive immunotherapy: requirement for T cell-deficient recipients. J. Exp. Med. 158:74.
5. Orme, I. M., A. D. Roberts, J. P. Griffin, and J. S. Abrams. 1993. Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection. J. Immunol. 151:518.
6. Cooper, A. M., D. K. Dalton, T. A. Steward, J. P. Griffin, D. G. Russel, and I. M. Orme. 1993. Disseminated tuberculosis in interferon-γ gene-disrupted mice. J. Exp. Med. 178:2243.
7. Flynn, J. L., J. Chan, K. H. Triebold, D. K. Dalton, T. A. Steward, and B. R. Bloom. 1993. An essential role for interferon-γ in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178:2249.
8. Cooper, A. M., A. D. Roberts, E. R. Rhoads, J. E. Callahan, D. M. Getzy, and I. M. Orme. 1995. The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection. Immunology 84:423.
9. Flynn, J. L., M. M. Goldstein, K. H. Triebold, J. Sypek, S. Wolf, and B. R. Bloom. 1995. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J. Immunol. 155:2515.
10. Nathan, C. 1992. Interferon and inflammation. In Inflammation: Basic Principles and Clinical Correlates. J. I. Gallin, I. M. Goldstein, and R. Snyderman, eds. Raven Press, New York, p 265.
11. Douvas, G. S., D. L. Looker, A. E. Vatter, and A. J. Crowle. 1985. γ-Interferon activates human macrophages to become tumoricidal and leishmanicidal but enhances replication of macrophages-associated Mycobacteria. Infect. Immun. 50:1.
12. 3, γ-interferon, and control of proliferation of Mycobacteria tuberculosis by human monocytes. Immunology 57:159.
13. Bermudez, L. E. M., and L. S. Young. 1988. Tumor necrosis factor, alone or in combination with IL-2, but not IFN-γ, is associated with macrophage killing of Mycobacterium avium complex. J. Immunol. 140:3006.
14. Shiratsuchi, H., J. L. Johnson, H. Toba, and J. J. Ellner. 1990. Strain-and donor-related differences in the interaction of Mycobacterium avium with human monocytes and its modulation by interferon-γ. J. Infect. Dis. 162:932.
15. Barnes, P. F., S. Fong, P. J. Brennan, P. E. Twomey, A. Mazumder, and R. L. Modlin. 1990. Local production of tumor necrosis factor and IFN-γ in tuberculous pleuritis. J. Immunol. 145:149.
16. Barnes, P. F., S. Lu, J. S. Abrams, E. Wang, M. Yamamura, and R. L. Modlin. 1993. Cytokine production at the site of disease in human tuberculosis. Infect. Immun. 61:3482.
17. Onwubalili, J. K., G. M. Scott, and J. A. R. Robinson. 1985. Deficient immune interferon production in tuberculosis. Clin. Exp. Immunol. 59:405.
18. Vilcek, J., A. Klion, D. Henriksen-deSteffano, A. Zemtsov, D. M. Davidson, M. Davidson, A. E. Freidman-Klein, and J. Le. 1986. Defective γ-interferon production in peripheral blood leukocytes of patients with acute tuberculosis. J. Clin. Immunol. 6:146.
19. Sanchez, F. O., J. I. Rodriguez, G. Agudelo, and L. F. Garcia. 1994. Immune responsiveness and lymphokine production in patients with tuberculosis and healthy controls. Infect. Immun. 62:5673.
20. Zhang, M,. Y. Lin, D. V. Iyer, J. Gong, J. S. Abrams, and P. F. Barnes. 1995. T-cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect. Immun. 63:3231.
21. Zhang, M., M. K. Gately, E. Wang, S. F. Wolf, S. Lu, R. L. Modlin, and P. F. Barnes. 1994. Interleukin-12 at the site of disease in tuberculosis. J. Clin. Invest. 93:1733.
22. Zhang, M., J. Gong, D. V. Iyer, B. E. Jones, R. L. Modlin, and P. F. Barnes. 1994. T-cell cytokine responses in persons with tuberculosis and human immunodeficiency virus infection. J. Clin. Invest. 94:2435.
23. Seder, R. A., K. H. Grabstein, J. A. Berzofsky, and J. F. McDyer. 1995. Cytokine interactions in human immunodeficiency virus-infected individuals: roles of interleukin (IL)-2, IL-12, and IL-15. J. Exp. Med. 182:1067.
24. Kindler, V., A. Sappino, G. E. Grau, P. Piguet, and P. Vassalli. 1989. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 56:731.
25. Bermudez, L. E., and G. Kaplan. 1995. Recombinant cytokines for controlling mycobacterial infections. Trends Microbiol. 3:22.
26. Tramontana, J. M., U. Utaipat, A. Molloy, P. Akarasewi, M. Burroughs, S. Makonkawkeyoon, B. Johnson, J. D. Klausner, W. Rom, and G. Kaplan. 1995. Thalidomide treatment reduces tumor necrosis factor α production and enhances weight gain in patients with pulmonary tuberculosis. Mol. Med. 1:384.
27. Moreno, C., J. Taverne, A. Mehlert, C. A. W. Bate, R. J. Brealey, A. Meager, G. A. W. Rook, and J. H. L. Playfair. 1989. Lipoarabinomannan from Mycobacterium tuberculosis induces the production of tumor necrosis factor from human and murine macrophages. Clin. Exp. Immunol. 76:240.
28. Barnes, P. F., D. Chatterjee, J. S. Abrams, S. Lu, E. Wang, M. Yamamura, P. J. Brennan, and R. L. Modlin. 1992. Cytokine production induced by Mycobacterium tuberculosis lipoarabinomannan. J. Immunol. 149:541.
29. Orange, J. S., T. P. Salazar-Mather, S. M. Opal, R. L. Spencer, A. H. Miller, B. S. McEwen, and C. A. Biron. 1995. Mechanism of interleukin 12-mediated toxicities during experimental viral infections: role of tumor necrosis factor and glucocorticoids. J. Exp. Med. 181:901.
30. Toossi, Z., P. Gogate, H. Shiratsuchi, T. Young, and J. J. Ellner. 1995. Enhanced production of TGF-β by blood monocytes from patients with active tuberculosis and presence of TGF-β in tuberculous granulomatous lung lesions. J. Immunol. 154:465.
31. Toossi, Z., M. E. Kleinhenz, and J. J. Ellner. 1986. Defective interleukin 2 production and responsiveness in human pulmonary tuberculosis. J. Exp. Med. 163: 1162.
32. Shiratsuchi, H., Y. Okuda, and I. Tsuyuguchi. 1987. Recombinani human interleukin-2 in vitro-deficient cell-mediated immune responses to tuberculin purified protein derivative by lymphocytes of tuberculous patients. Infect. Immun. 55: 2126.
33. Clerici, M., D. Lucey, J. A. Berzofsky, L. A. Pinto, T. A. Wynn, S. P. Blatt, M. J. Dolan, C. W. Hendrix, S. F. Wolf, and G. M. Shearer. 1993. Restoration of HTV-specific cell-mediated immune responses by interleukin-12 in vitro. Science 262:1721.
34. Murphy, E. E., G. Terres, S. E. Macatonia, C.-S. Heieh, J. Mattson, L. Lanier, M. Wysocka, G. Trinchieri, K. Murphy, and A. O'Garra. 1994. B7 and interleukin 12 cooperate for proliferation and interferon-γ production by mouse T helper clones that are unresponsive to B7 costimulation. J. Exp. Med. 180:223.
35. Kubin, M., M. Kamoun, and G. Trinchieri. 1994. Interleukin 12 synergizes with B7/CD28 interaction in inducing efficient proliferation and cytokine production of human T cells. J. Exp. Med. 180:211.
36. Sieling, P. A., D. Chatterjee, S. A. Porcelli, T. I. Prigoz, R. J. Mazzaccaro, T. Soriano, B. R. Bloom, M. B. Brenner, M. Kronenberg, P. J. Brennan, and R. L. Modlin. 1995. CD1 restricted T cell recognition of microbial lipoglycan antigens., Science 269:227.
37. - T lymphocytes to a microbial antigen. Nature 360:593.
38. Barnes, P. F., C. L. Grisso, J. S. Abrams, H. Band, T. H. Rea, and R. L. Modlin. 1992. γδ T lymphocytes in human tuberculosis. J. Infect. Dis. 165:506.
39. + αβ T cell and γδ T cell responses to Mycobacterium tuberculosis. J. Immunol. 154:1786.
40. Ohmen, J. D., P. F. Barnes, C. L. Grisso, B. R. Bloom, and R. L. Modlin. 1994. Evidence for a superantigen in human tuberculosis. Immunity 1:35.
41. Averill, L., Z. Toosi, H. Aung, W. H. Boom, and J. J. Ellner. 1995. Regulation of production of tumor necrosis factor a in monocytes stimulated by the 30-kilodalton antigen of Mycobacterium tuberculosis. Infect. Immun. 63:3206.
42. Shafer, R. W., A. B. Bloch, C. Larkin, V. Vasudavan, S. Seligman, J. D. Dehovitz, G. diFerdinando, R. Stoneburner, and G. Cauthen. 1996. Predictors of survival in HIV-infected tuberculosis patients. AIDS 10:269.
43. Beck, J. S., R. C. Polls, T. Kardjito, and J. M. Grange. 1985. T4 lymphopenia in patients with active pulmonary tuberculosis. Clin. Exp. Immunol. 60:49.
44. Onwubalili, J. K., A. J. Edwards, and L. Palmer, 1987. T4 lymphopenia in human tuberculosis. Tubercle 68:195.
45. + lymphocytopenia. Ann. Intern. Med. 119:55.
46. + T lymphocytopenia. J. Clin. Invest. 97:672.
47. Holland, S. M., M. D. Eisenstein, D. B. Kuhns, M. L. Turner, T. A. Fleisher, W. Strober, and J. I. Gallin. 1994. Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon γ. N. Engl. Med. 330:1348.